113617-63-3
Chemical Structure
Orbifloxacin
Synonym(s): CP-104354
- CAS No.: 113617-63-3
- Formula:C19H20F3N3O3
- Molecular Weight:395.38
IUPAC Name: 1-cyclopropyl-7-((3S,5R)-3,5-dimethylpiperazin-1-yl)-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
InChIKey: QIPQASLPWJVQMH-DTORHVGOSA-N
SMILES: O=C(C1=CN(C2CC2)C3=C(C(F)=C(F)C(N4C[C@H](C)N[C@H](C)C4)=C3F)C1=O)O
Biological Activity: Orbifloxacin is an orally administrable Antibiotic. Orbifloxacin disrupts the replication and proliferation of Bacterial DNA, inhibits bacterial growth and exerts bactericidal activity. Orbifloxacin inhibits the growth of canine-derived E. coli and Pseudomonas aeruginosa isolates. Orbifloxacin is used in research related to bacterial infections[1][2][3][4].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Orbifloxacin | 99.66% | Orbifloxacin is an orally administrable Antibiotic. Orbifloxacin disrupts the replication and proliferation of Bacterial DNA, inhibits bacterial growth and exerts bactericidal activity. Orbifloxacin inhibits the growth of canine-derived E. coli and Pseudomonas aeruginosa isolates. Orbifloxacin is used in research related to bacterial infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Orbifloxacin (Standard) | ≥98% | Orbifloxacin (Standard) is the analytical standard of Orbifloxacin. This product is intended for research and analytical applications. Orbifloxacin is an orally administrable Antibiotic. Orbifloxacin disrupts the replication and proliferation of Bacterial DNA, inhibits bacterial growth and exerts bactericidal activity. Orbifloxacin inhibits the growth of canine-derived E. coli and Pseudomonas aeruginosa isolates. Orbifloxacin is used in research related to bacterial infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Orbifloxacin-d5 hydrochloride | Orbifloxacin-d5 (hydrochloride) is a deuterated labeled Orbifloxacin. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Orbifloxacin-d4 | Orbifloxacin-d4 is deuterium labeled Orbifloxacin. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Beltrán JF, et al. Antibiotic discovery against Piscirickettsia salmonis using a combined in silico and in vitro approach. Microb Pathog. 2023;180:106122. [Content Brief]
- [2]. Zhong LG, et al. In vivo pharmacokinetic and pharmacodynamic profiles of orbifloxacin against Staphylococcus aureus in a neutropenic murine thigh infection model. BMC Vet Res. 2025;21(1):531. Published 2025 Aug 29. [Content Brief]
- [3]. Harada K, et al. Post-antibiotic effect of orbifloxacin against Escherichia coli and Pseudomonas aeruginosa isolates from dogs. Acta Vet Scand. 2012;54(1):16. Published 2012 Mar 20. [Content Brief]
- [4]. Ganière JP, et al. In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections. Res Vet Sci. 2004;77(1):67-71. [Content Brief]
